by Waylon Wright | Feb 27, 2018
Pearl Pathways is seeking an Office Administrator to join our team! The Office Administrator will work closely with the leadership team to enhance and develop business processes, assist with project management across the service delivery team and sales & marketing...
by Waylon Wright | Feb 20, 2018
Pearl Pathways announces the hiring of Heidi Unger as Regulatory Publication Analyst to support biopharmaceutical, medical device, and diagnostic life science companies. Unger brings over eighteen years of writing and editing experience within the book publishing...
by Waylon Wright | Feb 20, 2018
Diversity Alliance for Science (DA4S) is a non-profit organization that provides a platform to identify, attract, and develop small and/or diverse businesses to drive inclusive procurement practices in corporate, academic, and governmental entities within the life...
by Waylon Wright | Feb 14, 2018
Robert Seevers, Senior Advisor at Pearl Pathways, has been invited to deliver a lecture at Purdue University this Friday, February 16. Seevers will speak to an MS-level drug discovery class that aims to teach students how to apply and navigate current FDA regulations...
by Waylon Wright | Feb 6, 2018
The Center for Biologics Evaluation and Research (CBER) and Center for Drug Evaluation and Research (CDER) released the data standards strategy for 2018-2022 on Monday. The purpose of the CBER-CDER Data Standards Strategy is to reinforce the ongoing commitment to the...
